Follow
Simon Kaja, Ph.D.
Title
Cited by
Cited by
Year
A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression
AMJM van den Maagdenberg, D Pietrobon, T Pizzorusso, S Kaja, ...
Neuron 41 (5), 701-710, 2004
8102004
Voltage-gated ion channels in cancer cell proliferation
VR Rao, M Perez-Neut, S Kaja, S Gentile
Cancers 7 (2), 849-875, 2015
2012015
Quantification of lactate dehydrogenase for cell viability testing using cell lines and primary cultured astrocytes
S Kaja, AJ Payne, Y Naumchuk, P Koulen
Current protocols in toxicology 72 (1), 2.26. 1-2.26. 10, 2017
1522017
Smartphones in ophthalmology
J Chhablani, S Kaja, VA Shah
Indian journal of ophthalmology 60 (2), 127-131, 2012
1502012
Estrogen protects the inner retina from apoptosis and ischemia-induced loss of Vesl-1L/Homer 1c immunoreactive synaptic connections
S Kaja, SH Yang, J Wei, K Fujitani, R Liu, AM Brun-Zinkernagel, ...
Investigative ophthalmology & visual science 44 (7), 3155-3162, 2003
1002003
Crosstalk between MLO Y4 osteocytes and C2C12 muscle cells is mediated by the Wnt/β catenin pathway
J Huang, S Romero Suarez, N Lara, C Mo, S Kaja, L Brotto, SL Dallas, ...
Journal of Bone and Mineral Research Plus 1 (2), 86-100, 2017
982017
Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina
AJ Payne, S Kaja, Y Naumchuk, N Kunjukunju, P Koulen
International journal of molecular sciences 15 (2), 1865-1886, 2014
932014
Genetic models of migraine
RCG van de Ven, S Kaja, JJ Plomp, RR Frants, ...
Archives of neurology 64 (5), 643-646, 2007
892007
An optimized lactate dehydrogenase release assay for screening of drug candidates in neuroscience
S Kaja, AJ Payne, T Singh, JK Ghuman, EG Sieck, P Koulen
Journal of pharmacological and toxicological methods 73, 1-6, 2015
822015
Resveratrol and calcium signaling: molecular mechanisms and clinical relevance
AE McCalley, S Kaja, AJ Payne, P Koulen
Molecules 19 (6), 7327-7340, 2014
782014
Potassium channel activity controls breast cancer metastasis by affecting β-catenin signaling
EK Breuer, D Fukushiro-Lopes, A Dalheim, M Burnette, J Zartman, S Kaja, ...
Cell death & disease 10 (3), 180, 2019
722019
Control of intracellular calcium signaling as a neuroprotective strategy
RS Duncan, DL Goad, MA Grillo, S Kaja, AJ Payne, P Koulen
Molecules 15 (3), 1168-1195, 2010
712010
Intracellular mechanisms of N-acylethanolamine-mediated neuroprotection in a rat model of stroke
P Garg, RS Duncan, S Kaja, P Koulen
Neuroscience 166 (1), 252-262, 2010
612010
Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle …
S Kaja, RCG van de Ven, LAM Broos, H Veldman, JG van Dijk, ...
Neuroscience 135 (1), 81-95, 2005
612005
Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a‐mutant mouse rolling Nagoya
S Kaja, RCG Van De Ven, JG Van Dijk, JJGM Verschuuren, K Arahata, ...
European Journal of Neuroscience 25 (7), 2009-2020, 2007
582007
Caspase-3-dependent proteolytic cleavage of tau causes neurofibrillary tangles and results in cognitive impairment during normal aging
JC Means, BC Gerdes, S Kaja, N Sumien, AJ Payne, DA Stark, PK Borden, ...
Neurochemical research 41, 2278-2288, 2016
542016
Quantification of deficits in spatial visual function of mouse models for glaucoma
SL Burroughs, S Kaja, P Koulen
Investigative ophthalmology & visual science 52 (6), 3654-3659, 2011
522011
Novel mechanism of increased Ca2+ release following oxidative stress in neuronal cells involves type 2 inositol-1, 4, 5-trisphosphate receptors
S Kaja, RS Duncan, S Longoria, JD Hilgenberg, AJ Payne, NM Desai, ...
Neuroscience 175, 281-291, 2011
482011
Preclinical study of a Kv11. 1 potassium channel activator as antineoplastic approach for breast cancer
DF Fukushiro-Lopes, AD Hegel, V Rao, D Wyatt, A Baker, EK Breuer, ...
Oncotarget 9 (3), 3321, 2018
452018
Effects of dilution and prolonged storage with preservative in a polyethylene container on Bevacizumab (Avastin™) for topical delivery as a nasal spray in anti-hereditary …
S Kaja, JD Hilgenberg, E Everett, SE Olitsky, J Gossage, P Koulen
Human antibodies 20 (3-4), 95-101, 2011
392011
The system can't perform the operation now. Try again later.
Articles 1–20